Clinical Trial Update: A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous L-Citrulline to prevent complications from acute lung injury after cardiopulmonary bypass in children undergoing surgery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Septal Defect
• Primum Atrial Septal Defect
• Ventricular Septal Defect

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Ventricular Septal Defect, Atrioventricular Septal Defect | Phase 3 | Status: TERMINATED